RG1507
Sponsors
Hoffmann-La Roche
Conditions
Breast CancerNeoplasmsNon-Small Cell Lung CancerNon-Squamous Non-Small Cell Lung CancerSarcoma
Phase 1
A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.
CompletedNCT00400361
Start: 2006-04-30End: 2011-04-30Updated: 2016-11-02
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
CompletedNCT00560144
Start: 2007-12-31End: 2011-12-31Updated: 2016-11-01
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
TerminatedNCT00811993
Start: 2009-02-28End: 2012-12-31Updated: 2016-11-02
A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer
CompletedNCT00882674
Start: 2009-07-31End: 2010-12-31Updated: 2016-11-02
A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors
TerminatedNCT00985374
Start: 2009-11-30End: 2013-06-30Updated: 2016-11-02
Phase 2
A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
TerminatedNCT00642941
Start: 2007-12-18End: 2014-02-19Updated: 2021-02-03
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).
TerminatedNCT00760929
Start: 2008-11-10End: 2010-06-25Updated: 2021-01-05
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.
TerminatedNCT00773383
Start: 2008-11-30End: 2010-02-28Updated: 2013-06-24
A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer
TerminatedNCT00796107
Start: 2009-01-28End: 2010-03-03Updated: 2020-11-13